The decision to modify or discontinue GLP-1 therapy should always be made in consultation with your prescribing clinician, weighing the therapeutic benefits against the impact of side effects on quality of life
It may also not be recommended for some patients with pancreatitis, gallbladder disease, severe gastrointestinal concerns, pregnancy, or specific medication conflicts
You'll likely see some undissolved powder
Indeed, the gene (LPA) encoding apo(a) gene is a member of the plasminogen superfamily and given the similarities between apo(a) and plasminogen it has been hypothesized that apo(a) influences the processes of hemostasis
In this study, once-weekly subcutaneous injections of tirzepatide (5 mg, 10 mg, or 15 mg) were compared to once-daily subcutaneous injections of titrated insulin degludec